Literature DB >> 32475089

LI-RADS ancillary features on contrast-enhanced ultrasonography.

Christoph F Dietrich1,2, Yi Dong3, Yuko Kono4, Cosmin Caraiani5, Claude B Sirlin6, Xin-Wu Cui7, An Tang8.   

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) was created to standardize liver imaging in patients at high risk for hepatocellular carcinoma (HCC), and it uses a diagnostic algorithm to assign categories that reflect the relative probability of HCC, non-HCC malignancies, or benign focal liver lesions. In addition to major imaging features, ancillary features (AFs) are used by radiologists to refine the categorization of liver nodules. In the present document, we discuss and explain the application of AFs currently defined within the LI-RADS guidelines. We also explore possible additional AFs visible on contrast-enhanced ultrasonography (CEUS). Finally, we summarize the management of CEUS LI-RADS features, including the role of current and potential future AFs.

Entities:  

Keywords:  Contrast-enhanced ultrasound; Hepatocellular carcinoma; Ultrasonography

Year:  2020        PMID: 32475089     DOI: 10.14366/usg.19052

Source DB:  PubMed          Journal:  Ultrasonography        ISSN: 2288-5919


  2 in total

Review 1.  [Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine and critical care (CEUS Acute) : Consensus statement of DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM and DEGUM].

Authors:  Guido Michels; Rudolf Horn; Andreas Helfen; Andreas Hagendorff; Christian Jung; Beatrice Hoffmann; Natalie Jaspers; Horst Kinkel; Clemens-Alexander Greim; Fabian Knebel; Johann Bauersachs; Hans-Jörg Busch; Daniel Kiefl; Alexander O Spiel; Gernot Marx; Christoph F Dietrich
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-02       Impact factor: 0.840

2.  Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience.

Authors:  Adriana Ciocalteu; Sevastita Iordache; Sergiu Marian Cazacu; Cristiana Marinela Urhut; Sarmis Marian Sandulescu; Ana-Maria Ciurea; Adrian Saftoiu; Larisa Daniela Sandulescu
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.